MedTrace Logo

A Retrospective Review of FloSeal Use in Total Shoulder Arthroplasty

NCT01726972 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 41

Last updated 2020-10-23

No results posted yet for this study

Summary

The proposed study aims to objectively assess 2-year clinical and radiographic results for the rate of glenoid component loosening in total shoulder arthroplasty (TSA). This retrospective radiographic review will provide evidence for equivalence or superiority in curtailing loosening, a known complication in arthroplasty, when a hemostatic agent is utilized in conjunction with cement at the glenoid.

Conditions

  • Total Shoulder Arthroplasty
  • Glenohumeral Osteoarthritis

Sponsors & Collaborators

  • Western Orthopaedics Research and Education Foundation

    lead OTHER

Eligibility

Min Age
21 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2015-04-30
Completion
2015-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01726972 on ClinicalTrials.gov